(Q24674107)

2

0 references

J B Farmer

3

0 references

J C Hall

4

0 references

R G Humphries

5

0 references

F Ince

6

0 references

S E O'Connor

7

0 references

W T Simpson

8

0 references

G W Smith

British Journal of Pharmacology

9

0 references

language of work or name

English

0 references

publication date

July 1985

0 references

published in

0 references

volume

85

0 references

issue

3

0 references

page(s)

599-608

0 references

cites work

Dobutamine: development of a new catecholamine to selectively increase cardiac contractility

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1916510

EFFECT OF DOPAMINE IN MAN: AUGMENTATION OF SODIUM EXCRETION, GLOMERULAR FILTRATION RATE, AND RENAL PLASMA FLOW

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1916510

Analysis of histamine receptors in the central thermoregulatory mechanism of Mastomys natalensis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1916510

Cardiovascular dopamine receptors: physiological, pharmacological and therapeutic implications

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1916510

Cardiovascular and renal actions of dopamine: potential clinical applications

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1916510

Vasodilator therapy of cardiac failure (second of two parts).

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1916510

Modulation of noradrenergic transmission in the rabbit ear artery by dopamine

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1916510

Newer catecholamines for treatment of heart failure and shock: An update on dopamine and a first look at dobutamine

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1916510

Use of hexobendine to examine whether the coronary vasodilator metabolite released from guinea-pig isolated hearts is adenosine.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1916510

Characterization of the peripheral and central effects of SK&F 82526, a novel dopamine receptor agonist.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1916510

Differential blocking effects of several dopamine receptor antagonists for peripheral pre- and postsynaptic dopamine receptors in the anesthetized dog

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1916510

Negative inotropic effect of beta-blockers in the guinea-pig atrium after preincubation with isoprenaline.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1916510

Effects of dopamine and alpha-methyl-dopamine on smooth muscle and on the cardiac pacemaker

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1916510

Inhibition of noradrenaline uptake2 in the isolated rat heart by steroids, clonidine and methoxylated phenylethylamines

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1916510

Indirect sympathomimetic actions of dopamine.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1916510

The effects of dopexamine on the cardiovascular system of the dog

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1916510

Inhibition of the sympathetic nervous system by dopamine

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1916510

Dopamine decreases mesenteric blood flow in the anaesthetised dog through the stimulation of postsynaptic alpha 2-adrenoceptors.

30 May 2018

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FJ.1476-5381.1985.TB10554.X

Beta-adrenoceptor selectivity of dobutamine: in vivo and in vitro studies

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1916510

The Pharmacology of a β2-Selective Adrenoceptor Antagonist (ICI 118,551)

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1916510

Anesthetic-dopamine cardiac arrhythmias and their prevention by beta adrenergic blockade.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1916510

Comparison of the effects of dopamine, isoproterenol, norepinephrine and bradykinin on canine renal and femoral blood flow

28 November 2018

1 reference

12 December 2020

Effects of dopamine on renal function and hemodynamics in the dog

1 reference

12 December 2020

In vivo analysis of adrenergic receptor activity of dobutamine

1 reference

12 December 2020

Beneficial effect of salbutamol on cardiac function in severe congestive cardiomyopathy. Effect on systolic and diastolic function of the left ventricle

1 reference

12 December 2020

Structure activity relationships of N-substituted dopamine derivatives as agonists of the dopamine vascular and other cardiovascular receptors

1 reference

12 December 2020

Vasodilator therapy for chronic heart failure

1 reference

12 December 2020

Pirbuterol, an oral beta-adrenergic receptor agonist, in the treatment of chronic cardiac failure

1 reference

12 December 2020

Dopamine in the treatment of heart failure

1 reference

12 December 2020

Selective DA2 versus DA1 antagonist activity of domperidone in the periphery

1 reference

12 December 2020

SCH 23390 is a very potent and selective antagonist at vascular dopamine receptors.

1 reference

12 December 2020